What is Generate Biomedicines, Inc. 's retained earnings?

Generate Biomedicines, Inc. (GENB) reported retained earnings of -$737.74M in Q1 2026.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Generate Biomedicines, Inc. GENB Retained Earnings

Retained Earnings at other companies

MYR GroupMYRG

$549.78M+34.7%

SSR MiningSSRM

$402.67M+134%

Piper SandlerPIPR

$680.54M+22.3%

RepligenRGEN

$464.58M+12.4%

NNN REITNNN

-$902.26M-7.3%

CHE

ChemedCHE

$3.01B+8.2%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's retained earnings?: Generate Biomedicines, Inc. (GENB) reported retained earnings of -$737.74M in Q1 2026.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.